These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 33800954)
1. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Erickson MA; Rhea EM; Knopp RC; Banks WA Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators. Hachem M Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198 [TBL] [Abstract][Full Text] [Related]
3. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection. Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729 [TBL] [Abstract][Full Text] [Related]
4. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients. Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376 [TBL] [Abstract][Full Text] [Related]
5. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders. Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125 [TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance. Achar A; Ghosh C Cells; 2020 Oct; 9(11):. PubMed ID: 33120941 [TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Alam SB; Willows S; Kulka M; Sandhu JK Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 invasion of the central nervous: a brief review. Siddiqui R; Mungroo MR; Khan NA Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y Front Immunol; 2021; 12():697329. PubMed ID: 34386007 [TBL] [Abstract][Full Text] [Related]
11. Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms. Sharma S; Jagadeesh H; Saxena A; Chakravarthy H; Devanathan V J Biosci; 2021; 46(4):. PubMed ID: 34840148 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier. de Sousa AK; Magalhães DA; Ferreira JDS; Barbosa ALDR Med Hypotheses; 2020 Nov; 144():110213. PubMed ID: 33254519 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions. Kempuraj D; Aenlle KK; Cohen J; Mathew A; Isler D; Pangeni RP; Nathanson L; Theoharides TC; Klimas NG Neuroscientist; 2024 Aug; 30(4):421-439. PubMed ID: 37694571 [TBL] [Abstract][Full Text] [Related]
14. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Yachou Y; El Idrissi A; Belapasov V; Ait Benali S Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice. Qiao H; Deng X; Qiu L; Qu Y; Chiu Y; Chen F; Xia S; Muenzel C; Ge T; Zhang Z; Song P; Bonnin A; Zhao Z; Yuan W J Med Virol; 2024 May; 96(5):e29671. PubMed ID: 38747003 [TBL] [Abstract][Full Text] [Related]
16. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Welcome MO; Mastorakis NE Inflammopharmacology; 2021 Aug; 29(4):939-963. PubMed ID: 33822324 [TBL] [Abstract][Full Text] [Related]
17. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125 [TBL] [Abstract][Full Text] [Related]
18. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders? Murta V; Villarreal A; Ramos AJ ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468 [TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism. Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]